Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01132053|
Recruitment Status : Completed
First Posted : May 27, 2010
Last Update Posted : February 27, 2019
|Condition or disease|
|Progressive Multifocal Leukoencephalopathy|
|Study Type :||Observational|
|Actual Enrollment :||126 participants|
|Official Title:||Role of Inflammation in PML|
|Actual Study Start Date :||June 2004|
|Actual Primary Completion Date :||September 2016|
|Actual Study Completion Date :||December 2018|
These are subjects who have confirmed PML.
These are subjects who do not have PML. They may be healthy or immune compromised due to Cancer, Transplant, or HIV.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01132053
|United States, Massachusetts|
|Beth Israel Deaconess Medical Center|
|Boston, Massachusetts, United States, 02215|
|Principal Investigator:||Chen S Tan, MD||Beth Israel Deaconess Medical Center|